Trends in cancer prognosis in a population-based cohort survey: Can recent advances in cancer therapy affect the prognosis?
Eri Kawabata-Shoda(Astellas Pharma (Japan)), Shoichiro Tsugane(International University of Health and Welfare), Motoki Iwasaki, Hiromichi Kimura(The University of Tokyo), Taiki Yamaji, Sachiko Masuda(The University of Tokyo), Norie Sawada(National Cancer Center), Manami Inoue(Fukuoka University), Hadrien Charvat(Juntendo University), Taichi Shimazu, Ai Ikeda(Harvard University), Shizuka Sasazuki
Cited by 10
Related Papers
Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
|Nature Medicine|2019|1.5k
Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study
|The Lancet Oncology|2021|684
What has made the population of Japan healthy?
|The Lancet|2011|677
Genome-wide association study identifies 112 new loci for body mass index in the Japanese population
|Nature Genetics|2017|510
Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts
|JNCI Journal of the National Cancer Institute|2018|285